close

Fundraisings and IPOs

1 60 61 62 63 64 67
Number of results: 1334
Date Company Amount Funding type Investors Therapeutic area Type of Information
2011-09-06 Amakem (Belgium) € 18 million Series A financing round Forbion Capital Partners (The Netherlands) - Crédit Agricole Private Equity (France) - Vesalius BioCapital (Luxembourg) - LRM (Belgium) - PMV (Belgium) - Life Sciences Research Partners (Belgium) Ophtalmological diseases Fundraising
2011-09-06 Theralpha (France) €2.55 million grant Eurobiomed cluster as part of the 12th FUI (Fond Unique Interministeriel) (France) - Conseil Général 06 (France) - Région PACA (France) - Communauté du Pays d\'Aix en Provence (France) - Clermont Communauté (France) CNS diseases Grant
2011-09-05 Telormedix (Switzerland) € 729,500 grant European Eurostars Programme (EU) Cancer - Oncology - Inflammatory diseases Grant
2011-08-25 Mission Therapeutics (UK) £6 million series A round Sofinnova Partners (France) - Imperial Innovations (UK) - SR One  (UK) - Roche Venture Fund (Switzerland) Cancer - Oncology Fundraising
2011-08-25 Aleva Neurotherapeutics (Switzerland) €9.5 million Series A financing round BioMedInvest AG (Switzerland) - BB BIOTECH VENTURES III, L.P. Initiative Capital Romandie  (Switzerland) - private investors Technology - Services - Neurodegenerative diseases Fundraising
2011-08-24 Genfit (France) €5.3 million Yorkville Advisors (USA) Cardiovascular diseases - Metabolic diseases - Liver diseases Fundraising
2011-08-23 KalVista Pharmaceuticals (UK) £8 million series A financing round Novo A/S (Denmark) - SV Life Sciences (UK - USA) Ophtalmological diseases Fundraising
2011-08-22 Autifony Therapeutics (UK) £10m (€11.4 million) financing round Imperial Innovations Group (UK) - SV Life Sciences (UK - USA) Otorhinolaryngology Fundraising
2011-08-15 Evolva (Switzerland) CHF 30 million (€26.4 million) private placement YA Global -Yorkville Advisors LLC (USA) Technology - Services Fundraising
2011-08-06 ugichem (Austria) €2 million equity financing round - grant The BioScience Venture Group (Germany) - Fonds 3 KG - V+ M GmbH & Co (Germany) - Swiss private investors - Austrian Research Promotion Agency (FFG) (Austria) Autoimmune diseases – Inflammatory diseases Grant
2011-07-27 ChronTech Pharma (Sweden) 25 million SEK (€2.7 million) private placement Sunninghill Investments Ltd - Dr. Simon Kukes - Dr. Prem Lachman - the Chairman of the Board, Mr Thomas Lynch Technology - Services - Infectious diseases Private placement
2011-07-26 BioAlliance Pharma (France) €16.64 million capital increase Cancer - Oncology - Rare diseases Capital increase
2011-07-25 Summit (UK) £1.35 million private placement existing and new investors Rare diseases - Neuromuscular diseases - Infectious diseases Private placement
2011-07-25 CEVEC Pharmaceuticals (Germany) €6 million financing round NRW.BANK (Germany) - Creathor Venture Fonds (Germany) - a group of private and institutional investors - ERP Startfonds of KfW bank (Germany) Technology - Services Fundraising
2011-07-21 Pharming (The Netherlands) €3.2 million private placement new US based specialist investors Rare diseases Private placement
2011-07-14 Ark Therapeutics (UK) €5.3 million grant European Commission’s Seventh Framework Program (FP7) Cardiovascular diseases Grant
2011-07-14 Lophius Biosciences (Germany) €1.4 Million financing round All current financial investors of the company Translantation - Infectious diseases Fundraising
2011-07-06 Antisense Pharma - now Isarna Therapeutics (Germany) € 8 million capital increase MIG Funds 2, 3 and 9
GAF
Cancer - Oncology - Ophtalmological diseases - Fibrotic diseases Capital increase
2011-07-06 Vantia Therapeutics (UK) £4 million (€ 4.55 million) series B financing round Novo A/S (Denmark) - SV Life Sciences (UK - USA) - MVM Life Science Partners (UK) Women health Fundraising
2011-07-06 Ark Therapeutics (UK) €0.6 million grant Technology - Services Grant